Cargando…
Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis
BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596990/ https://www.ncbi.nlm.nih.gov/pubmed/36313770 http://dx.doi.org/10.3389/fendo.2022.984593 |
_version_ | 1784815993303859200 |
---|---|
author | Han, Mingyue Wang, Yao Jin, Yuanhui Zhao, Xue Cui, Haiying Wang, Guixia Gang, Xiaokun |
author_facet | Han, Mingyue Wang, Yao Jin, Yuanhui Zhao, Xue Cui, Haiying Wang, Guixia Gang, Xiaokun |
author_sort | Han, Mingyue |
collection | PubMed |
description | BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship between different types of benign thyroid disease and the risk of breast cancer, furthermore, assessing whether benign thyroid disease exerts an influence on the aggressiveness of breast cancer. METHOD: A systematic literature search (PubMed, Web of Science, MEDLINE, and Embase databases) identified studies to evaluate the correlation between BTD and BC risk. Data were analyzed using version 16.0 STATA software, including the odds ratio (OR) and its corresponding 95% confidence intervals (CIs). Publication bias and quality assessment were conducted for the included studies. RESULT: Overall, 18 studies involving 422,384 patients with BTD were incorporated. The outcome showed that autoimmune thyroiditis (OR: 2.56, 95%CI: 1.95–3.37, I(2 =) 0.0%, p=0.460), goiter (OR: 2.13, 95%CI: 1.19-3.79, I(2 =) 80.6%, p=0.000), and Graves’ disease (OR: 5.01, 95%CI: 1.49-16.82, I(2 =) 0.0%, p=0.358) was connected with a higher risk of BC. Both hypothyroidism (OR: 0.82, 95%CI: 0.64-1.04, I(2 =) 85.0%, p=0.000) and hyperthyroidism (OR: 1.07, 95%CI: 0.93-1.24, I(2 =) 24.9%, p=0.206) had no significant association with the risk of BC. Additionally, the pooled analysis showed no apparent correlation between BTD and aggressiveness of BC. However, subgroup analysis indicated a positive relationship between BTD and aggressiveness of BC in the Europe subgroup (HR: 2.05, 95%CI: 1.32-3.17, I(2 =) 86.4%, p=0.000). CONCLUSION: Autoimmune thyroiditis, goiter, and Graves’ disease are connected with an increased risk of BC. Furthermore, subgroup analysis suggested that BTD increases the aggressiveness of BC in the European population geographically. Nevertheless, further research is needed to prove these discoveries. |
format | Online Article Text |
id | pubmed-9596990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95969902022-10-27 Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis Han, Mingyue Wang, Yao Jin, Yuanhui Zhao, Xue Cui, Haiying Wang, Guixia Gang, Xiaokun Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The correlation between benign thyroid disease (BTD) and breast cancer (BC) has long been discussed. However, the definite relationship and potential mechanism between them are still disputed. The current meta-analysis aimed at performing a comprehensive assessment of the relationship between different types of benign thyroid disease and the risk of breast cancer, furthermore, assessing whether benign thyroid disease exerts an influence on the aggressiveness of breast cancer. METHOD: A systematic literature search (PubMed, Web of Science, MEDLINE, and Embase databases) identified studies to evaluate the correlation between BTD and BC risk. Data were analyzed using version 16.0 STATA software, including the odds ratio (OR) and its corresponding 95% confidence intervals (CIs). Publication bias and quality assessment were conducted for the included studies. RESULT: Overall, 18 studies involving 422,384 patients with BTD were incorporated. The outcome showed that autoimmune thyroiditis (OR: 2.56, 95%CI: 1.95–3.37, I(2 =) 0.0%, p=0.460), goiter (OR: 2.13, 95%CI: 1.19-3.79, I(2 =) 80.6%, p=0.000), and Graves’ disease (OR: 5.01, 95%CI: 1.49-16.82, I(2 =) 0.0%, p=0.358) was connected with a higher risk of BC. Both hypothyroidism (OR: 0.82, 95%CI: 0.64-1.04, I(2 =) 85.0%, p=0.000) and hyperthyroidism (OR: 1.07, 95%CI: 0.93-1.24, I(2 =) 24.9%, p=0.206) had no significant association with the risk of BC. Additionally, the pooled analysis showed no apparent correlation between BTD and aggressiveness of BC. However, subgroup analysis indicated a positive relationship between BTD and aggressiveness of BC in the Europe subgroup (HR: 2.05, 95%CI: 1.32-3.17, I(2 =) 86.4%, p=0.000). CONCLUSION: Autoimmune thyroiditis, goiter, and Graves’ disease are connected with an increased risk of BC. Furthermore, subgroup analysis suggested that BTD increases the aggressiveness of BC in the European population geographically. Nevertheless, further research is needed to prove these discoveries. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9596990/ /pubmed/36313770 http://dx.doi.org/10.3389/fendo.2022.984593 Text en Copyright © 2022 Han, Wang, Jin, Zhao, Cui, Wang and Gang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Han, Mingyue Wang, Yao Jin, Yuanhui Zhao, Xue Cui, Haiying Wang, Guixia Gang, Xiaokun Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title | Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title_full | Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title_fullStr | Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title_full_unstemmed | Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title_short | Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis |
title_sort | benign thyroid disease and the risk of breast cancer: an updated systematic review and meta-analysis |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596990/ https://www.ncbi.nlm.nih.gov/pubmed/36313770 http://dx.doi.org/10.3389/fendo.2022.984593 |
work_keys_str_mv | AT hanmingyue benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT wangyao benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT jinyuanhui benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT zhaoxue benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT cuihaiying benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT wangguixia benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis AT gangxiaokun benignthyroiddiseaseandtheriskofbreastcanceranupdatedsystematicreviewandmetaanalysis |